A SCHOOL-BASED PROGRAM TO PREVENT INHALANT USE IN ALASKA

描述（由申请人提供）：一项针对美国印第安人的基于证据的药物滥用预防计划的三年研究，旨在打击不同比例的阿拉斯加原住民（尤皮克人、廷吉特人和因纽特人）、高加索人和其他人群中青少年的吸入剂使用和其他药物使用。本研究的目的是：(a)调整一个以证据为基础的毒品预防项目，以便在阿拉斯加农村小学实施；(b)进行一个试点测试，以评估其实施质量、可能与实施质量相关的因素、项目效果以及可能解释所注意到的任何项目效果的因素。本研究的主要结果是认知和行为技能中介，被认为是调解该计划对青少年前吸入剂使用的潜在影响。为了取得这些成果，一个以证据为基础的学校毒品预防培训项目将被调整，以提高阿拉斯加农村社区青少年抵制吸入剂使用的认知和行为技能。阿拉斯加农村地区16个社区的学校系统已经同意参与这项研究，其中8对社区将被随机分配到实验和控制条件下。这16个社区，其中大部分只有一所小学，将代表二级和三级服务中心的混合物，以及位于该州不同地区的阿拉斯加原住民村庄，人口规模从433到8,835不等。这项研究将把注意力集中在减少毒品问题上，这个问题在高风险和服务不足的人群中很少受到关注。

DESCRIPTION (provided by applicant): A three-year study of an adapted evidence-based substance abuse prevention program for American Indians is proposed to combat inhalant use and other drug use among youth in communities with varying proportions of Alaska Natives (Yupik, Tingit, and Inupiat), Caucasians, and other populations. The study aims are to (a) adapt an evidence-based drug prevention program to be implemented in rural Alaska elementary schools and (b) conduct a pilot test to assess its implementation quality, factors that may be associated with implementation quality, program effects, and factors that might explain any program effects noted. The primary outcomes of this study are cognitive and behavioral skills mediators that are believed to mediate the program's potential effects on inhalant use among pre-adolescents. To achieve these outcomes, an evidence-based school drug prevention training program will be adapted to increase cognitive and behavioral skills to resist the use of inhalants among pre-adolescents in rural Alaskan communities. Agreements have been obtained from school systems in 16 communities in rural Alaska to participate in the study in which eight pairs of communities will be randomly assigned to experimental and control conditions. The 16 communities, most of which only have only one elementary school, will represent a mixture of secondary and tertiary service centers and feeder Alaska Native villages that are located in various regions of the state, with population size ranging from 433 to 8,835. This study will focus attention on reducing a drug problem that has received little attention among a high risk and underserved population.